P0828 Crohn’s disease patients respond better to vedolizumab if biologic-naïve
S Dijkstra(Utrecht University), Bas Oldenburg(University Medical Center Utrecht), M Lutgens(St. Elisabeth Hospital), J P D Schultheiss(Utrecht University), F van Wijk(University Medical Center Utrecht), C S Horjus Talabur Horje(Rijnstate Hospital), H Fidder(Utrecht University), W Mares(Ziekenhuis Gelderse Vallei), Bindia Jharap(Meander Medisch Centrum)
Cited by 0
Related Papers
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial
|The Lancet Oncology|2011|470
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252